Biologics Contract Manufacturing Expansion Europe · 8d ago

Curia Invests $5.61 Million in Precision Fermentation Facility in León, Spain, Expanding Capacity to 58,000 Liters

Curia completes a €5M precision fermentation expansion in León, Spain, boosting capacity to 58,000 liters with new USP and DSP equipment and upgraded utili

RD

Research Desk

· 2 min read

Curia Invests $5.61 Million in Precision Fermentation Facility in León, Spain, Expanding Capacity to 58,000 Liters

Curia Global Inc. has finished a USD 5.61 million expansion at its León, Spain operations, a project that delivers a new precision fermentation facility and raises the site's capacity to 58,000 liters.

The contract research, development, and manufacturing organization (CDMO) announced the completion of the project from Albany, NY.

Equipment Installed Across USP and DSP

At the heart of the investment is a purpose-built facility housing fermentation, or upstream processing (USP), equipment alongside downstream processing (DSP) equipment.

According to the company, this combination enables optimized manufacturing flows and supports development and scale-up activities through capacity enablement and upgraded site utilities. The new equipment installations bring the facility's total capacity to 58,000 L.

Critical Utility Systems Brought Online

Beyond the production floor, the project also covered the installation of critical utility systems needed to fully support the new production building. Curia stated that these upgrades are intended to provide a reliable utility supply across production operations.

Jamie Grabowski, President of R&D at Curia, framed the work as part of the company's commitment to supporting customers with reliable, efficient manufacturing and flexible capacity as programs advance.

"By aligning our equipment footprint and upgrading essential utilities, we are building a strong foundation for sustained performance at León," Grabowski said.

What León Does for Curia's Customers

The León site specializes in biotechnology development, fermentation production, and downstream processing, serving customers across the pharmaceutical, cosmetic, agriculture, and food industries.

Curia characterized the expansion as a reflection of its continued focus on strengthening its manufacturing network, ensuring its sites are equipped to meet evolving customer needs through dependable operations and high standards of quality.

The Company Behind the Expansion

Curia is a CDMO with over 30 years of experience, operating an integrated network of more than 20 global sites staffed by 3,100 employees who partner with biopharmaceutical customers to bring therapies to market.

Its offerings cover small molecules, generic APIs, and biologics, spanning discovery through commercialization, with integrated regulatory, analytical, and sterile fill-finish capabilities.

The company's services extend across both drug substance and drug product manufacturing.

Tracked in the database

Biologics Contract Manufacturing Expansion · Europe

Category

Biologics Contract Manufacturing Expansion

Region

Europe

Industry

Chemical

Published

10 November 2026

Length

2 min read

Tagged

CDMO ExpansionPrecision FermentationBiomanufacturing CapacityPharmaceutical Manufacturing

Live from the tracker

The projects behind these stories

Capacity, capex, stage, contractors and verified contacts for every project we track, updated daily.

LLY - Lebanon Medicine Foundry · Indiana, United States · Not disclosed · On-going / Under Construction LLY - Project Savannah Biomanufacturing Facility · Texas, United States · Not disclosed · Planning LLY - Huntsville Medicines Manufacturing Plant · Alabama, United States · Not disclosed · Planning NOVO-B - Clayton Aseptic and Finished Product Manufacturing Plant · North Carolina, United States · Not disclosed · On-going / Under Construction LLY - Pleasant Prairie Pharmaceutical Manufacturing Facility Expansion · Wisconsin, United States · Not disclosed · Planning EDCL - Gopalganj Vaccine Manufacturing Plant · Dhaka Division, Bangladesh · Not disclosed · Planning FF - Holly Springs Cell Culture Biomanufacturing Plant · North Carolina, United States · Not disclosed · On-going / Under Construction LLY - Leiden Bio Science Park Pharmaceutical Manufacturing Plant · Netherlands · Not disclosed · Planning LLY - Alzey Pharmaceuticals Production Plant · Rhineland-Palatinate, Germany · Not disclosed · On-going / Under Construction BAYN - New Albany Pharmaceutical Manufacturing Plant · Ohio, United States · Not disclosed · Planning LLY - Lebanon Medicine Foundry · Indiana, United States · Not disclosed · On-going / Under Construction LLY - Project Savannah Biomanufacturing Facility · Texas, United States · Not disclosed · Planning LLY - Huntsville Medicines Manufacturing Plant · Alabama, United States · Not disclosed · Planning NOVO-B - Clayton Aseptic and Finished Product Manufacturing Plant · North Carolina, United States · Not disclosed · On-going / Under Construction LLY - Pleasant Prairie Pharmaceutical Manufacturing Facility Expansion · Wisconsin, United States · Not disclosed · Planning EDCL - Gopalganj Vaccine Manufacturing Plant · Dhaka Division, Bangladesh · Not disclosed · Planning FF - Holly Springs Cell Culture Biomanufacturing Plant · North Carolina, United States · Not disclosed · On-going / Under Construction LLY - Leiden Bio Science Park Pharmaceutical Manufacturing Plant · Netherlands · Not disclosed · Planning LLY - Alzey Pharmaceuticals Production Plant · Rhineland-Palatinate, Germany · Not disclosed · On-going / Under Construction BAYN - New Albany Pharmaceutical Manufacturing Plant · Ohio, United States · Not disclosed · Planning